TY  - GEN 
AU  - Tay, A.H.M.
AU  - Prieto-Díaz, R.
AU  - Neo, S.
AU  - Tong, L.
AU  - Chen, X.
AU  - Carannante, V.
AU  - Önfelt, B.
AU  - Hartman, J.
AU  - Haglund, F.
AU  - Majellaro, M.
AU  - Azuaje, J.
AU  - Garcia-Mera, X.
AU  - Brea Floriani, José Manuel
AU  - Loza García, María Isabel
AU  - Jespers, W.
AU  - Gutierrez-De-Teran, H.
AU  - Sotelo, E.
AU  - Lundqvist, A.
PY  - 2022
SN  - 2051-1426
UR  - http://hdl.handle.net/20.500.11940/20665
AB  - Background Adenosine is a metabolite that suppresses antitumor immune response of T and NK cells via extracellular binding to the two subtypes of adenosine-2 receptors, A 2 ARs. While blockade of the A 2A ARs subtype effectively rescues lymphocyte...
LA  - eng
TI  - A 2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
DO  - 10.1136/jitc-2022-004592
KW  - AS Santiago
KW  - IDIS
VL  - 10
ER  -